uconn

EMERGE Emergency Funding Program

The University of Connecticut EMERGE Program provides short-term (<12 months) essential support when external funding for an investigator has been interrupted due to circumstances (broadly related to recent changes in federal policies and priorities) beyond the investigator’s control.

This program is provided through a collaboration among faculty, departments, and schools/colleges, centers/institutes, the OVPR, and the Provost’s Office. The distribution of EMERGE funds is contingent upon contributed funds from faculty, departments, schools/colleges, and/or centers/institutes based on existing unrestricted funds available.

EMERGE funds will be available in two phases. Phase 1 is limited to emergency, non-cancellable, university-obligated costs that are not recoverable as unavoidable costs on the project. Phase 2 provides bridge or seed funding to support an investigator in pursuing alternative funding mechanisms.

The EMERGE program will accept applications on a rolling basis. Reviews will be performed every 2 weeks with a goal for decisions within 3 weeks of submission. The three weeks begins once the application has been approved by unit leaders

Pre-submission Requirements

EMERGE program requests must meet several conditions:

  1. The program is intended for cases where current, active grants or contracts have been terminated or interrupted (i.e., paused) for reasons beyond the investigator’s control. Other situations may be considered on a case-by-case basis, provided that recent changes in federal funding policies and practices cause the funding gap to be addressed.

 

  1. Phase 1 funds Funding priority is for the base salaries and fringe of graduate students, postdocs, and other externally funded personnel costs up to the amount currently funded on the impacted grants or contracts. Other critical research expenses outside of salaries may be considered with justification. Summer salary is excluded from EMERGE requests.

 

Phase 2 funds: Can include any costs in Phase 1, plus other expenses needed to support an investigator in the pursuit of new external funding through pilot projects and/or completing critical aims/tasks from terminated projects and/or helping a graduate student complete their degree.

 

  1. Contributions from PI, Co-PI, department, school/college, and/or Center/Institute funds are expected based on available unrestricted fund balances (startup, IDC, salary savings, or any other accounts that may be used for research costs). Faculty, department heads/chairs, deans, and directors are empowered to work collaboratively on plans to make funds available for contribution. Contributions for emergency needs will vary based on the local funds available. Where available balances allow, local and school/college contributions will likely need to exceed the third/third/third model previously used for OVPR matches. This will allow the OVPR to reserve limited central funds for units with low discretionary balances. This allocation of university resources is also imperative given the state’s attention to the university’s unrestricted account balances. The OVPR has cut programs/resources (e.g., internal seed grants, research development and communication resources) to pay costs associated with the EMERGE program.

 

  1. PIs applying for EMERGE funds must work with their department, center/institute, and school/college leadership while preparing their financial and action plans.
    • All financial resources available to the applicant should be examined. For example, if the investigator has over $10,000 in start-up or other discretionary funds, the OVPR expects the investigator to deplete those funds below $10,000 collectively as part of the financial plans.
    • The role of the department head / dean / director is to render their best judgment regarding the applicant’s need for emergency funds in the context of the applicant’s other support and department / school / college / center / institute resources, and the applicant’s plans for restoring funding.
    • Applications must have Department and School/College approval prior to submission
    • All applications for EMERGE funds will be routed to the department head, dean and/or director for confirmation (the same approvals as IPRs).

 

  1. If extramural grant funds (for the project in question) become available to the investigator during the period of the EMERGE award, any future unused funds must be returned. For example, it is expected that graduate student/staff supported by EMERGE funds would be transitioned back to external funding on reinstated or new related award

 

  1. To receive funds under the EMERGE program, PIs must be up-to-date/compliant with all training requirements, including new trainings related Research Security.

 

  1. Requests to the OVPR must be initiated through the EMERGE intake application (available through the UConn Quest Portal). Applications may be submitted by the PI, the Department/Center, or the Dean’s office.

Phase 1 – Application and Review Process

Applications may be submitted through the UConn Quest Portal, (you may be prompted to first log in and then to click the link again to access the application) and must include the following components:

Note: Phase 1 and Phase 2 applications may be submitted together, if desired; however, we recommend taking time to fully consider phase 2 plans before submitting a phase 2 application.

  • Application Form – available on Quest Portal
    • Applicant Information
    • Background information regarding request
    • Financial contribution overview
  • Request Details (*uploaded as PDF – no more than 3 pages). Please include the following sections:
    • EMERGE Rationale:
      • Please describe the circumstances motivating the request for emergency funding
      • If applicable, please include an overview of grants that have been cancelled (date of notification, expected end date, reason for cancellation, etc.) 
      • For requests not including cancellations, please describe the federal action that is causing the emergency, any communications you’ve received from the sponsor, and any backup plans you have prepared. 
    • Immediate university-obligated / non-cancellable costs: EMERGE Phase 1 awards can support University obligated/critical costs that would have been covered by a grant if not for the action described in the previous section.  Please include: 
      • An overview of personnel (students, postdocs, staff) costs that can no longer be charged to the grant, as expected
        • Include details about their current contract timeline, other sources of funding for their position (if any), and notice requirements for their positions if they cannot be continued.
        • If a contract end date extends beyond the expected end date of any terminated grants, please describe your original plans for supporting the position after the grant’s end.
      • A description of any other critical research expenses necessary to safely close out the project.
      • Any steps taken or commitments received that mitigate the impact of the federal action This can include shifting impacted personnel to other projects/duties, offers of TAships/fellowships, or commitments of cash support.
      • Please work with your local financial / grant administrators and SPS Post Award to ensure all information is accurate.   
    • Action Plans, with timelines What activities do you propose to undertake during the EMERGE Phase 1 award period? Please outline: 
      • Steps you are taking to minimize project-related costs.
      • Steps needed to scale down, reconfigure, or potentially close out the impacted project in an orderly fashion Please complete this even if you also plan to apply for phase 2 funds.  
      • The activities that personnel funded by EMERGE phase 1 would do during the award period.
      • Any project activities/deliverables that can be completed using EMERGE phase 1 support This can include completing in-progress activities previously funded by terminated awards or activities that can help you pivot to new funding. 
    • Staffing plans  EMERGE Phase 1 funds can only support personnel for the duration of the University’s current obligation (end of contract or end of layoff period, if applicable) Please share a brief overview of: 
      • Plans for impacted staff beyond the phase 1 award period (may include new assignments for impacted personnel). 
      • Plans to support impacted students through the end of their degree programs. 
      • Any special circumstances (e.g., international considerations, etc.) 
  • Budget Spreadsheet (uploaded as PDF) - Note: we have not yet established a particular format for the budget spreadsheet.
    • Budgets should reflect the full non-cancellable costs related to the project for the emergency period, after cost minimizing steps are taken. 
    • Contributions from the PI, department, center/institute, and school/college should be accounted for in the budget.  All project-related costs should be included.
    • Budget should include:
      • Eligible Personnel costs, including benefit fringe rates at this link; university fringe benefit rates, (Storrs and regional campuses) and university fringe benefit rates (UConn Health Center) broken down by individual categories 
      • Other critical costs that are required and/or cannot be deferred, in detail (e.g., animal care, equipment maintenance)  
      • Itemize contributions from PI, department, school/college, affiliated centers/institutes 
    • Please also provide a separate sheet listing all active PI accounts, including foundation accounts, indicating 
      • Current balances
      • Amounts being committed for the current request
      • Other existing short/near term commitments for available funds, if any.
  • Optional Appendices (uploaded as PDF) may be uploaded.
      • such as but not limited to; letters of support, termination notices, hiring contracts, references/sources or any other information in support of the application

Phase 1 Review Process

  1. After submission, the request will be routed to Department, Center/Institute, and School/College leadership for review and approval. Unit leaders will need to sign off on action plans and financial commitments.
  2. Requests will then be reviewed by the OVPR, along with a representative of the EMERGE committee in the case of Storrs and Regional Campus submission and HCRAC for UConn Health submissions.
    • All available accounts related to the request will be reviewed. For PIs, uncommitted fund balances above $10K (cumulative across all unrestricted accounts) must be put toward funding needs related to the terminated project.
    • Action and staffing plans will be reviewed to ensure that they are complete and well-justified.
  3. Reviews will be performed every 2 weeks with a goal for decisions within 3 weeks of submission. The three weeks begins once the application has been approved by unit leaders, as described above in #1.
  4. Awards will be dependent on availability of EMERGE funding.

EMERGE Committee will be comprised of at least 5 members with representation from the following groups: OVPR Research Development, Center/Institute directors, Associate Deans for Research.

Phase 2 – Application and Review Process

Applications may be submitted through the UConn Quest Portal, (you may be prompted to first log in and then to click the link again to access the application) and must include the following components:

Note: Phase 1 and Phase 2 applications may be submitted together, if desired; however, we recommend taking time to fully consider phase 2 plans before submitting a phase 2 application.

  • Application Form – available on Quest Portal
    • Applicant Information
    • Background information regarding request
    • Financial contribution overview
  • Request Details (*uploaded as PDF – no more than 3 pages). Please include the following sections:
    • Reason for request
    • Action Plans, with timelines
      • Proposed short-term research plan and milestones
      • Future funding plans to pursue new external funding
      • How this funding will help investigator(s) win future funding
  • Budget Spreadsheet (uploaded as PDF) Note: we have not yet established a particular format for the budget spreadsheet.
    • Eligible Personnel costs, including university fringe benefit rates, broken down by individual
    • Other research-related costs (materials and supplies, equipment, animal costs, participant costs, facility use fees, etc).
    • Itemize contributions from PI, department, school/college, affiliated centers/institutes
    • Separate sheet listing all active PI accounts, including foundation accounts, indicating:
      • Current balance
      • Overlap with current request
      • Existing short/near term commitments for available funds, if any
  • Optional Appendices (uploaded as PDF) may be uploaded.
    • such as but not limited to; letters of support, termination notices, hiring contracts, references/sources or any other information in support of the application

Phase 2 Review Process

  1. After submission, the request will be routed to Department, Center/Institute, and School/College leadership for review and approval. Unit leaders will need to sign off on the merit of proposed research, the likelihood of future external funding, and all financial commitments.
  2. Requests will then be reviewed by the OVPR, along with a representative of the EMERGE committee in the case of Storrs and Regional Campus submission and HCRAC for UConn Health submissions.
    • All available accounts related to the request will be reviewed. For PIs, uncommitted fund balances above $10K (cumulative across all unrestricted accounts) must be put toward funding needs related to the terminated project.
    • Research and future funding plans will be reviewed to ensure that they are complete and well-justified. OVPR will rely upon the judgement of unit leaders regarding the intellectual merit of the proposed research.
  3. Reviews will be performed every 2 weeks with a goal for decisions within 3 weeks of submission. The three weeks begins once the application has been approved by unit leaders, as described above in #1.
  4. Awards will be dependent on availability of EMERGE funding.
  5. EMERGE awards will be made for 6 month increments. Demonstration of progress is required to receive a subsequent allocation, if needed, and if funds are available.

EMERGE Committee will be comprised of at least 5 members with representation from the following groups: OVPR Research Development, Center/Institute directors, Associate Deans for Research.

EMERGE Award – What to do if additional funds become available

As the purpose of Emerge is to temporarily stabilize emergency situations caused by grant terminations or other unanticipated actions related to federal funding policies, gaining access to new external funds to support the impacted work and personnel is a main expected outcome for EMERGE awards.  Therefore, if new external dollars become available to EMERGE awardees, they must work with the OVPR to determine how the new funds will be applied to offset EMERGE funds and to determine whether an emergency still exists. 

Emerge guideline language: If extramural grant funds (for the project in question) become available to the investigator during the period of the EMERGE award, any future unused funds must be returned. For example, it is expected that graduate student/staff supported by EMERGE funds would be transitioned back to external funding on a reinstated or new related award 

 Typically, “new external funding” can be broken down into two broad categories: 1) new funds freed up related to a terminated award and 2) new external awards (more details and definitions are supplied below). 

Action Steps 

Additional support related to the terminated award becomes available (i.e. carryover, additional costs covered by sponsor during closeout, etc.) 

  • If an EMERGE-funded team receives word that new funds related to a previously terminated award may be available, they must email OVPR (research@uconn.edu) with CC to other contributors (Department, Center/Institute, School/College) as soon as possible. 
  • Please share the amount of funding expected, when funds will be available, and if there are any expectations or limits from the sponsor on how the funds can be used.   
  • It is expected that any additional funds related to the terminated award will be used to support EMERGE-funded activities, except as required by the sponsor. 
  • Any such additional funds must be drawn from first to pay for costs related to EMERGE-Phase 1 and possibly Phase 2. (to be evaluated on a case-by-case basis) 
  • EMERGE funds that are displaced by additional sponsor support will be returned to the OVPR so they can be reinvested. 


 New external funding awards are received  

  • If an EMERGE-funded team receives new external funding awards, they must reach out to the OVPR (research@uconn.edu) with CC to other contributors (Department, Center/Institute, School/College) as soon as the official notice of award is received.   
  • Please share the amount of funding expected and the anticipated start date of the award.   
  • Please share a brief abstract of the project and a high-level overview of the personnel involved. 
  • The EMERGE committee will review high-level information about the new award and advise on the next steps. 
  • In most cases, the arrival of new external funds indicates that the emergency funding gap addressed by the EMERGE award has been alleviated, and the Committee will provide guidance on closing out the EMERGE award and transitioning personnel and activities to the new external funding source. 
  • In rare cases, availability of new external funds may not fully alleviate the emergency conditions addressed by EMERGE.  PIs in these circumstances should reach out to the OVPR (research@uconn.edu) to discuss their options. 

Postaward Reporting

After awards are made, midpoint progress reports are required in order to receive the second installment of funds for awards (if applicable) when the award period is 12 months. A final progress report is required once the project has been completed. The QUEST portal will notify awardees when a midpoint or a final report is due. If you have any questions, please contact research@uconn.edu.

Contact

Contact: If you have questions about the application process, the materials needed, or regarding a funded request, please contact the OVPR Triage Team at research@uconn.edu.

BIS Request Power BI Access

View the SPS Quarterly Report (Power BI version)

FIRST Click the link above for the Power BI SPS Quarterly Report to determine if you already have access to the report.

If you are unable to reach the SPS Quarterly Report-Power BI version using the link above, please complete the form below to get access.

You will need to use your UConn Email and NetID credentials to log into the Power BI application. If you don’t know or have not activated your NetID, please visit the NetID Management webpage for assistance.

You will receive an email when your SPS Quarterly Report (Power BI version) access request has been processed.

BIS Access Request

Request access to SPS Quarterly Report (Power BI version)

This field is for validation purposes and should be left unchanged.
Name(Required)
Email (UConn/UCH)(Required)
Please provide any necessary additional information.
Please provide your UConn NetID. This is a combination of 3 characters and 5 digits.

Business Integrations and Solutions (BIS)

Business Process Improvement and Project Support, System Development and Support, Data Integrity and Reporting

The Business Integrations and Solutions (BIS) team helps keep UConn’s research systems running smoothly. We build and support tools used by Sponsored Program Services and others involved in research administration, making sure everything connects and shares data the way it should. Whether it’s developing new apps with our partners at Internal Insights and Innovation (i3), managing system integrations, providing useful reports and analyses, or working with SPS units to improve business processes, we’re behind the scenes making it all work better and more efficiently.

 

If you need assistance with OVPR applications, please refer to our InfoEd support website, our ERC help website, or log a support ticket by emailing our eRA Help Desk.

IBC Minutes

 

Effective June 1, 2025, the UConn IBC will make approved meeting minutes publicly available, by posting records on this site.

This procedure is pursuant to the provisions outlined in the NIH OSP Memorandum “Implementation Update: Promoting Maximal Transparency Under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules” (NIH Notice: NOT-OD-25-082).

In compliance with the NIH Guidelines, the IBC meeting minutes document the committee’s review of experiments that fall within the scope of Section III. Research activities not subject to the NIH Guidelines are not reflected in these records.

 

IBC Minutes

March 5, 2026

February 5, 2026

January 15, 2026

December 11, 2025

November 6, 2025

October 2, 2025

September 4, 2025

August 7, 2025

June 12, 2025

 


 

In accordance with state FOI and the requirements of the NIH Guidelines, only approved IBC minutes will be posted publicly. Records in draft form are not subject to public records requests. Please refer to the NIH OSP FAQs IBC Meetings and Minutes for additional details. The UConn IBC follows current NIH guidance to ensure compliance

 

 

Institutional Biosafety Committee

Mission Statement:

The Institutional Biosafety Committee (IBC) of the University of Connecticut (UConn) is committed to promoting the advancement of research and teaching activities, by ensuring that all experiments involving biological materials are conducted in full compliance with local, state, and federal regulations and guidelines. As required by the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines), all institutions that conduct research with recombinant/synthetic nucleic acids (rsNA) and receive NIH funding, must maintain an active IBC. With the cooperative effort of Principal Investigators (PIs), the IBC conducts risk assessments for hazards associated with the use of biological materials, and promotes the safe use of such materials by enhancing lab personnel’s understanding of biosafety practices and procedures, as defined in the Biosafety in Microbiological and Biomedical Laboratories (BMBL) issued by the Centers for Disease Control and Prevention (CDC).

Overview:

Pursuant to Section IV-B-2 of the NIH Guidelines, the IBC was originally established to review and approve “Experiments Covered by the NIH Guidelines”, as defined under Section III. Compliance with the NIH Guidelines is a requirement for institutions that accept NIH funding and conduct covered experiments. As such, compliance with the Guidelines is a term and condition of funding for all labs at UConn working with rsNA, regardless of funding source.

Due to increased regulations and rapid advancements in life sciences research, the scope of the IBC has evolved over time. IBC approval is required for all biological materials including but not limited to:

  • recombinant or synthetic nucleic acid molecules (rsNA),
  • bacteria, their phages and plasmids,
  • viruses and viral vectors,
  • biological toxins,
  • fungi, prions and parasites,
  • human and animal cells, blood, tissues, body fluids, etc.,
  • transgenic and wild type animals, plants, and
  • animal remains and insects that may harbor zoonotic pathogens.

The IBC collaborates with Biosafety to ensure compliance with other federal and state regulations, such as Connecticut Department of Public Health (DPH), Centers for Disease Control and Prevention (CDC), Animal Plant Health Inspection Service (APHIS), etc.

Committee Membership:

 

The IBC is actively recruiting new committee members!

If you are interested in joining an exciting committee that oversees biological research at UConn, email ibc@uconn.edu or the IBC Program Director at danielle.delage@uconn.edu.

The IBC must comprise no fewer than five members. At least two members shall not be affiliated with the institution (apart from membership on the IBC). Unaffiliated members represent the interest of the surrounding community with respect to health and protection of the environment.

UConn’s IBC consists of faculty, staff, and unaffiliated community members. All committee members contribute to the professional competency necessary to review the broad scope of research and teaching activities at the University.

 

Last Revised: 03/03/2025

Institutional Biosafety Committee

Mission Statement:

The Institutional Biosafety Committee (IBC) of the University of Connecticut (UConn) is committed to promoting the advancement of research and teaching activities, by ensuring that all experiments involving biological materials are conducted in full compliance with local, state, and federal regulations and guidelines. As required by the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines), all institutions that conduct research with recombinant/synthetic nucleic acids (rsNA) and receive NIH funding, must maintain an active IBC. With the cooperative effort of Principal Investigators (PIs), the IBC conducts risk assessments for hazards associated with the use of biological materials, and promotes the safe use of such materials by enhancing lab personnel’s understanding of biosafety practices and procedures, as defined in the Biosafety in Microbiological and Biomedical Laboratories (BMBL) issued by the Centers for Disease Control and Prevention (CDC).

Overview:

Pursuant to Section IV-B-2 of the NIH Guidelines, the IBC was originally established to review and approve “Experiments Covered by the NIH Guidelines”, as defined under Section III. Compliance with the NIH Guidelines is a requirement for institutions that accept NIH funding and conduct covered experiments. As such, compliance with the Guidelines is a term and condition of funding for all labs at UConn working with rsNA, regardless of funding source.

Due to an increase in regulatory oversight as well as rapid advancements in life sciences research, the scope of the IBC has evolved over time, to include all work with biological materials.

IBC Registrations are required for the storage, use, or handling of biological materials.

 

Biological Materials include, but are not limited to:

  • recombinant or synthetic nucleic acid molecules (rsNA),
  • bacteria, their phages and plasmids,
  • viruses and viral vectors,
  • biological toxins,
  • fungi, prions and parasites,
  • human and animal cells, blood, tissues, body fluids, etc.,
  • transgenic and wild type animals, plants, and
  • animal remains and insects that may harbor zoonotic pathogens.

The IBC collaborates with Biosafety to ensure compliance with other federal and state regulations, such as Connecticut Department of Public Health (DPH), Centers for Disease Control and Prevention (CDC), Animal Plant Health Inspection Service (APHIS), etc.

Committee Membership:

The IBC must comprise no fewer than five members. At least two members shall not be affiliated with the institution (apart from membership on the IBC). Unaffiliated members represent the interest of the surrounding community with respect to health and protection of the environment.

UConn’s IBC consists of faculty, staff, and unaffiliated community members. All committee members contribute to the professional competency necessary to review the broad scope of research and teaching activities at the University.

If you are interested in joining an exciting committee that oversees biological research at UConn, email ibc@uconn.edu or the IBC Program Director at danielle.delage@uconn.edu.

 

News & Announcements:

NIH Office of Science Policy (OSP) — Biosafety Modernization Initiative

NIH has launched an initiative to update biosafety policies and oversight to address emerging risks from rapidly advancing science and technology. To support this effort, OSP plans to strengthen partnerships with institutional oversight bodies and reinforce the role of IBCs, aligning with other oversight committees such as IRBs and IACUCs.

NIH is requesting feedback from stakeholders (researchers, IBC members, etc.) regarding what they think should be included in a modern biosafety policy. A portal has been established for public comment on this initiative, which is linked below:

While comments submitted through the portal can relate to any aspect of biosafety oversight, NIH is particularly interested in hearing individual opinions regarding:

  • Appropriate scope for NIH’s biosafety policy
  • Types of research that may require less local or NIH oversight based on accrued safety data or due to oversight by other federal authorities
  • Other comments on NIH’s biosafety oversight

Be sure to follow University Policy when submitting personal comments.

Disclaimer Example: The opinions expressed are my own and do not reflect the views or positions of the University of Connecticut.

For additional information, please visit the NIH OSP website: https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy#tab2/

 

Last Revised: 12/16/2025

Guidelines – Stop Work Orders

Federal Stop-Work or Grant Termination Directives

These guidelines are intended to assist investigators who may be at risk for or have received a directive from a federal funding agency to stop, pause, terminate or otherwise prematurely end a human research study.  Please contact the IRB Office if you have any questions or need assistance.

 

UConn Quantum Technologies Translation Award (QuTech) Program

The Quantum Technologies Translation Award Program (QuTech), made possible through investments by the Connecticut Office of Innovation (CTNext), supports the derisking of use-inspired innovations centered on quantum and quantum adjacent technologies through Academic / Industry partnerships.  The program provides up to $30,000 to help accelerate the translation of UConn/UCH developed quantum and quantum adjacent technologies / applications for real world impact. QuTech is open to UConn/UCH researchers who have:

  1. Completed research and developed (at minimum) a Proof of Concept,
  2. A use-inspired application with strong market potential and a path for IP protection, and
  3. A partnership with an established quantum-related company or startup (the proposing team cannot have an ownership stake in the partner company).

Funds can be used for:

  1. Supporting students to conduct experiments designed to de-risk the technology for targeted applications,
  2. External validation of the technology and/or its use cases with an industry and/or startup partner, and/or
  3. Use of in-house or external resources critical for de-risking the technology.

Applications will be reviewed by internal and external researchers familiar with quantum technologies and/or associated markets.

Important Dates (all due dates by 12 noon) 

  • 5/15/25 – program opens.
  • 6/30/25 Full Proposal deadline.  Submissions are made via the UConn Quest Portal
  • Award Notifications are expected in August, 2025

Award details:

  • The OVPR anticipates funding up to 2 awards of $30,000.
  • Award periods will be for one year
  • Awards will be funded in two equal payments.  The second payment will be made six months into the award period, pending completion of milestones, submission of a report, and adherence to program guidelines.
  • QuTech awards are intended to support the translation of quantum-related innovations developed within the labs / research groups of UConn/UConn Health faculty members.  Funds cannot be used for
    • a) continuing previous/ongoing commercialization projects,
    • b) costs related to creating/operating start-up companies, or
    • c) development activities that take place within startup companies.
  • Awardees will be connected with commercialization experts from OVPR’s Technology Commercialization and Venture Development group.  Awardees should expect to work closely with TCS to discuss progress/obstacles, undergo commercialization-related training, and to gain access to advice and resources that will enhance the project’s chances for commercial success.  Awardees are required to work with TCS's IP team to protect their innovation (target: provisional patent filing 6 months to 1 year after project launch).

Eligibility / IP & Licensing Requirements:

The QuTech program is available to UConn/UConn Health faculty members, within the following parameters:

  • IP: Projects should have intellectual property at their core. To be eligible, project-related UConn IP must exist and a UConn invention disclosure must be filed prior to applying.  Projects based on IP not developed at UConn are not eligible.
  • Startups and License Options: If a startup related to the QuTech project exists at the time of award, an option agreement must be taken within 6 months of the award.  If a startup company related to the project is formed at any point in the future, an option agreement must be taken within six months of the startup creation.
  • Effort and Salary:
    • The award does not pay for any PI salary or for time spent on the project
    • Although no minimum effort level is required for QuTech projects, a PI/Co-PI must have institutionally-funded research time available during the award period to lead and complete the project.
    • Research Professors / those whose positions are contingent on grant-funding (soft money positions) must include details about their institutionally-funded research time as part of the budget justification to confirm eligibility.
  • UConn Primary Appointment:
    • PIs must be faculty or staff whose primary appointment is at UConn/UConn Health. Awards are available to tenure-track, tenured, Clinical, Research, and in-Residence faculty with Assistant Professor rank or higher.
    • Researchers with primary appointments to CCMC, Jackson Labs, or TIP or other startup companies are not eligible to apply.
    • Individuals who are not eligible to apply as a PI may be able to serve as a collaborator/consultant on an eligible PI’s project.
  • Number of submissions: Eligible faculty may only submit one proposal as lead PI. Investigators may serve as collaborator on multiple projects.

Proposal Submission Instructions:

Elements to include in the full application are as follows:

  1. A one-paragraph abstract (type or copy/paste into a form on Quest).
  2. Project plan document three page maximum, 11-pt font and 1” margins), including
    1. Problem/Unmet need: Describe the problem or unmet need that the innovation will address.
    2. Description of the innovation: Describe the innovation or technology concept.
    3. Estimate Market Size:
      1. Which industries are likely to adopt the technology? Why is this technology important for these industries?
      2. Please describe the total available market this technology addresses (TAM) and how much of the TAM this technology will address.
    4. Competing Products:
      1. Identify any currently available products/technologies and explain why they do not adequately satisfy the problem or unmet need.
      2. Explain how the proposed innovation is different from or better than those that are already available.
    5. Intellectual property (IP): Describe your IP position, and the competitive IP landscape. List your current patent applications or patents pending as well as any granted patents related to this project. If you currently have no patent applications, please mention plans for future invention disclosures.
    6. Commercialization Plan:
      1. Explain how the proposed de-risking activities will allow you to achieve the major milestones required to further develop the technology for market entry.
      2. Describe your plans for funding development of this technology beyond the QuTech grant (through SBIR/STTR, Angel and VC funding, etc).
    7. Preliminary evidence: Summarize any preliminary data available that substantiates the proposed innovation usefulness for the applications envisioned.
    8. Proposed work with project milestones: Outline the proposed scope of work approaches with timelines and a clearly defined set of objective milestones to be completed by the end of the initial award period.  Please include an analysis of how the proposed activities will sufficiently de-risk the innovation to allow for further commercial development.
  3. Biosketches/CVs: Please include brief biosketches/CVs (formatted as appropriate for your field) for all PIs/Co-PIs (No more than 3 pages).  Include your most recent publications or those most relevant to the work proposed.  Also include current/pending support from external sponsors and UConn sources (including start-up funding).  Biosketches/CVs may be uploaded as one PDF or as separate PDF documents.
  4. Budget: Provide a preliminary budget estimate and proposed use of funds. Please see Internal Funding Budget Guidelines for instructions and a budget template.
  5. The budget spreadsheet should be converted to PDF format prior to upload.

              Review Criteria

              Proposals will be scored based on the following criteria:

               

              Market Need—does the innovation address an unmet need and is there evidence that there is a market for the proposed solution?

              • Does the applicant make a strong case that there is a need/problem that needs to be met?
              • Is the science/technology strong enough to evidence its success
              • Does the proposal include data about how much of the market the technology may realistically capture?

               

              Innovation and Novelty—Is the innovation novel and/or does it make a significant improvement over currently-available solutions?

              • Does the proposal make a convincing argument that the innovation is novel and or makes a significant improvement over currently-available solutions?
              • Is there existing or the potential for intellectual property protection?
              • To what degree does the innovation solve the unmet need differently (e.g., better, faster, cheaper) than the current state-of-the art?
              • If novel, is the innovation a disruptive technology, a platform technology, or an incremental improvement over the current state-of-the art?

               

              Commercialization Plan—Is there a realistic path for commercializing the innovation?

              • Does the proposal present a path to bring the innovation forward to market?
              • Does the proposal present plans for future financing of the project, such as SBIR/STTR or industry investment?
              • For future development, will this technology require regulatory approval?  If so, does the proposal address plans for successfully navigating the process?
              • Does the applicant point to any obvious potential licenses / commercial partners for this innovation?

               

              Approach and Feasibility—Are the activities proposed attainable in the proposed timeline and are they consistent with the high scientific/scholarly standards?

              • Does the investigator/team have appropriate expertise and laboratory facilities available to conduct the work?
              • Does the project include the involvement of a UConn core facility or a third party be required to complete the work (e.g prototype development)?  If so, have appropriate commitments been obtained?
              • To what degree will the activities proposed de-risk and advance the development of the innovation?

               

              Postaward Considerations

              QuTech awardees agree to provide regular progress reports to the OVPR during and after the award period. Reports fall into four categories:

              • Consultations with TCS: Awardees are expected to connect regularly throughout the award period with their point of contact within OVPR Technology Commercialization Services to discuss progress, to talk through potential problems, and to consider future steps and additional resources that may be of use. Each PI will work with their TCS contact to set up the best check-in schedule, but it is expected that consultations would happen at least on a quarterly basis.
              • Six-month Reporting: After six months of each award period, applicants will be asked to submit a progress report via the Quest Portal.  After review of this report, the second payment of the award period will be made to the award account.
              • Annual Reports: Recognizing that investments made by the OVPR can often take some time to produce their full results, we will be asking that all recipients of OVPR Internal Funding, including QuTech, submit outcomes reports over the life of the project. This will allow us to better understand the impact of internal funding and make the case for it continuing / increasing.
                • Reporting requirements: PIs will need to prepare a brief report, using this Award Report Template to summarize project progress within one month of posting final expenses unless an extension from the OVPR has been received.
                  • We’ll be interested in hearing about the results of your project,
                  • the significance of those results, and
                  • gathering statistics about graduate students supported, publications, external grants / patents received, other projects launched, etc.
                  • Other questions may also be included as needed. The OVPR may request updates annually for up to five years following the end of the award period to track the development of the project longitudinally.

              Program Contacts

              The QuTech program is jointly administered by OVPR Technology Commercialization Services and Internal Funding Program.

              Program Director
              Dr. Vivek Ramakrishnan
              Director, Venture Development, OVPR Technology Commercialization Services
              vivek.ramakrishnan@uconn.edu

              Dr. Matt Mroz
              Manager, Research Development Services
              matthew.mroz@uconn.edu

              Program point of contact (Contact for information on program/process, application status, award management/extensions)

              Charlotte Nelson
              Internal Funding Coordinator
              research@uconn.edu

              MPS Seed Grant Program

              Overview

              The OVPR’s MPS Seed Grant Program is to provide funding support for UConn/UCH researchers to use the School of Pharmacy and Pharmaceutical Sciences’ Javelin MPS (microphysiological system or organ-on-a-chip platform), recently acquired thanks to a generous gift by UConn Aluma Jane Hirsh, to generate preliminary data in support of grant submissions.

              The OVPR is providing one-time matching funds in response to Ms. Hirsh’s gift because of the strong potential MPS and other new approach methodologies (NAMs) offers for reducing the need for animal studies in human health research and speeding up the development of new therapeutics. The use of MPS and other NAMs in health research is in strong alignment with FDA, NIH, and international efforts to develop ethical, human-specific non-animal methodologies. OVPR offers this seed investment to enable UConn/UCH researchers to effectively leverage these new approaches for high-impact research that can establish the University as a leader in this promising area.

              Award Details

              The MPS Seed Grant Program will award 8-10 grants up to $25,000 each to cover the experimental costs described below.

              Proposed research projects should include the design and the execution of Javelin’s organ-on-a-chip platform studies that addresss high-value questions such as.

              • Population and species differences in metabolism
              • Mechanisms of off-target toxicity
              • Optimization of dosing regimens using human-relevant models
              • Efficacy, ADME, or toxicity assessment for promising therapeutics

                Awards include funds to support up to two rounds of experiments. Budgets can only be used to support the following costs:

                • Chips from Javelin
                • Reagents and other supplies needed to carry out experiments using the Javelin platform

                Expected outcomes

                • External fund proposals seeking NIH, FDA, and foundation support for alternative testing strategies. Applicants need to name their targeted external funding opportunities and provide details about expected submission timelines.
                • Peer-reviewed manuscripts, conference presentations at regional and national meetings focused on MPS and pharmacology.
                • Other visible outputs that will reinforce UConn’s reputation as a hub for innovative, ethical drug development science.

                Timeline

                • Full proposals must be submitted by 4/6 at 12 noon via the UConn Quest Portal (you may be prompted to first log in and then click the link again to access the application)
                • Notifications of results will be announced by May 15th, 2026
                • Awardees will be announced publicly on the OVPR’s Internal Funding Program website and through UConn Today.

                Funding Period

                Awards will be made for a 6-month period, with the expectation is experiments will be completed within 6 months unless a compelling justification is made by the PI(s) for an alternate funding period. Standard award period will be June 1 to December 31. Projects that are expected to take more than 9 months to complete are not encouraged.

                Budget

                In the application, please indicate how many chips (each chip costs $850.00) are needed and the amount of funds needed for reagents. (total amount not to exceed $25,000.00)

                Eligibility

                • Lead faculty PI needs to be a UConn/UCH faculty member
                • Faculty must be tenure-track, tenured, Research, and in-Residence faculty with Assistant Professor rank or higher with an active research program.  Investigators need to have institutionally-funded research time available to devote to the project.
                • Faculty may only submit one proposal as lead PI. Investigators may serve as collaborators on multiple projects.
                • Multi-PI, interdisciplinary projects are encouraged. Faculty are encouraged to use the School’s website or Lincus, a search engine that will assist in identifying specific faculty expertise at all UConn campuses, including UConn Health. You can also reach out to OVPR Research Development Associate Quinn McAdam at mcadam@uconn.edu.

                Guidelines

                PROPOSAL GUIDELINES

                Please be sure to read all the guidelines thoroughly. Each item/section should be prepared, labeled, and ordered as indicated below.  Some information will need to be entered into a form on the application site.  Other documents will need to be uploaded.  See below for details.

                Proposals must be submitted electronically through the UConn Quest Portal by 4/6 and will require the following information:

                Faculty Applicant Information Form (some information may pre-populate into the form)

                • Submitting PI Name
                • Home Department
                • School/College
                • Email
                • Phone
                • Faculty/Academic Rank
                • Primary Employer
                • Question - is your position contingent on grant funding?

                MPS SEED GRANT APPLICATION FORM

                Faculty Applicant Information

                • Special Reviewer Expertise (optional): If your project requires reviewers to possess specific expertise within the context of your discipline (i.e. familiarity with a specialized approach or methodology), please specify.
                • Size of Team: 0-8
                • Key Personnel: Co-PIs, department affiliation, role on project
                • Project Title:
                • Total Amount Requested for Reagents and Chips: (not to exceed $25,000.00)
                • Total Amount Requested for Reagents:
                • Total Cost of Chips: (each chip costs $850.00)
                • Project Abstract / Lay Summary: Succinctly state (for a non-specialist audience) the objectives, methods to be employed, and the significance of the proposed activity.
                • Future Funding and/or Activities: The applicant should specify where extramural grant proposals will be submitted and/or the high-level disciplinary accomplishments that will result from the MPS Seed Grant Program award.
                • Keywords: List 4-5 keywords relevant to project

                Project Plan (PDF upload)

                The Project Plan should be 2-3 pages in length (12-pt font and 1” margins). The Project Plan should address each of the areas below in sufficient detail using the headings provided. Proposals should be written in straightforward language, keeping in mind that reviewers will possess general content knowledge but not necessarily specialist expertise. Proposals should avoid the use of technical jargon. Acronyms that are not universally understood should be spelled out the first time they are used.  References should be included in the project plan document, but they do not need to be counted against page limits

                Significance/Importance: Provide a clear and compelling scientific rationale for the proposed project and how using the MPS platform will accelerate research progress in your chose area of inquiry. Narratives should address both the significance of the scientific questions being explored and the significance of using MPS techniques in the project.

                Approach and Feasibility: Describe the plan for carrying out the proposed activities, including research aims, design, work plan, and methodological approach.

                Overview of future work enabled by these pilot studies:

                  • Identify the external funding opportunities you are targeting (sponsor, specific funding opportunity, targeted submission dates).
                  • Briefly describe the team that you will gather for the external submission.
                  • Describe other expected research products (publications, presentations, etc.) that you expect to emerge from the project.
                  • Describe how the preliminary data produced using this funding will improve your competitiveness for external funding.

                Biosketches/CVs (PDF upload, single document)

                Please include biosketches/CVs (formatted as appropriate for your field) for all PIs/Co-PIs.  Include your most recent publications or those most relevant to the work proposed.  Also include current/pending support from external sponsors and UConn sources (including start-up funding). This may be appended to the end of the CV/biosketch or integrated within it, if your discipline format already provides space for current/pending.

                Appendices (PDF upload, single document)

                Additional information may be included when it is truly essential for adequate peer review of the proposal.

                            Review Criteria

                            Review Process

                            All proposals will be evaluated by the OVPR for eligibility, then assigned to reviewers whose expertise aligns with the proposals.  The reviewers will in turn recommend proposal(s) for funding to the Faculty Co-chairs who will make final funding recommendations to the OVPR.

                            • The Faculty Co-chairs provide reviewer suggestions to be invited to review specific proposals. (2 reviewers for each proposal)
                            • The OVPR will invite reviewers based on disciplinary areas consistent with the proposal category, scholarly reputation, and expertise and specialization consistent with the proposal topic.
                            • Once the reviews are complete, the Faculty Co-chairs will review the recommendations by the reviewers, identify the strongest proposals for funding, and select the proposal(s) to be recommended for funding, keeping the review criteria in mind.

                            Review Criteria

                            Using a 5-point rating scale from 1 (Excellent) to 5 (Poor), reviewers will rate and evaluate 3 criteria (Significance, Approach/ Feasibility and Overview of future work enabled by these pilot studies in alignment with the MPS Seed Grant Program mission to support innovative and collaborative research using Javelin’s MPS (organ-on-a-chip platform).

                             Significance/Importance

                            • Does this study clearly address an important scientific problem in a way that successfully leverages the MPS platform?
                            • If the aims of the project are achieved, will scientific knowledge, technical capability, clinical practice, and/or social conditions be advanced in meaningful ways?
                            • Does the proposed project significantly contribute to the concepts, theories, methods, technologies, applications, treatments, outcomes, services, and/or preventive interventions?

                            Approach/Feasibility

                            • To what degree does the proposal outline a clearly articulated and well-reasoned plan of action that includes activities, research aims, design and work plan?
                            • To what degree are the proposed approaches appropriate for the aims of the project? Do they reflect intellectual rigor?
                            • To what degree is the project, as described in the proposal, achievable?  Are there any concerns about feasibility?
                            • Does the environment in which the work will be done contribute to the probability of success?

                            Overview of future work enabled by these pilot studies

                            • Are the identified external funding opportunities targets within the next year?
                            • To what extent are the selected funding opportunities appropriate for the proposed project?
                            • If the proposed project is successful, to what extent will the team’s competitiveness for the targeted external funding opportunities be improved? 

                            Postaward Reporting

                            After awards are made and the project has been completed, the OVPR would like to evaluate project progress and to learn more about the impact on the work that has been done.  To this end, you will receive a link to a short survey asking questions about the outcomes and impacts of your project; publications, abstracts, external grant applications, patents, and awards related to the MPS Seed Grant Program once your project has been completed.

                            Program Contacts

                            PROGRAM CONTACTS

                            Program Director: Matt Mroz, Interim Director of Research Development, OVPR
                            Email: matthew.mroz@uconn.edu

                            Technical Content Contact: Xiaobo Zhong, Professor of Pharmacology & Toxicology, Pharmaceutical Sciences
                            Email: xiaobo.zhong@uconn.edu

                            Administrative Contact: Charlotte Nelson, Internal Funding Coordinator, OVPR
                            Email: research@uconn.edu

                            Reminder: Transition Amendments for UConn IRB

                            The IRB module of InfoEd was updated on December 16th.  For the system to work as intended, most open studies will need to be transitioned to the new application form:

                             

                            The following studies need to be migrated:

                            • Open studies that received approval or exemption determination from UConn Storrs IRB prior to the system updates (December 16, 2024);
                            • Open studies that were approved by an external, non-UConn IRB, that have a record in InfoEd.

                            The following projects do not need to be migrated:

                            • Research studies that are closed;
                            • Determinations that a project is not research or projects that are determined not to involve human subjects (aka NHSR determinations);
                            • Projects for which data collection is complete, and the only remaining activities are data analysis;
                            • Projects that can be closed because they no longer involve human subjects.

                            When are transition amendments due?

                            • Projects that require continuing review with the continuing review application submitted after March 16, 2025 must have been migrated to the new form via a transition amendment prior to the continuation. 
                            • Effective March 16, 2025, projects that do not require continuing review must be updated via a transition amendment the next time a submission to the IRB is needed. 

                            For more information, please see the Study Migration Guide. User Guides are also available on the Human Subjects Module webpage.

                             

                             

                            Register for IRB Office Hours – Human Subjects Research Support

                            The Research Integrity & Compliance (RIC) team invites students and faculty to attend virtual (via Webex) and in-person office hours for assistance with IRB submissions and human subjects research regulations.

                            RIC staff will be available to answer questions regarding IRB submissions, human subjects regulations, post-approval support, and general IRB guidance.

                             

                            Office hours schedule:

                            • Wednesday February 26, 2025: 10:00am – 1:00pm (In Person)

                                      Location: Whetten Graduate Center, 2nd floor, Room 211

                             

                            • Tuesday March 4, 2025: 1:00pm – 4:00pm (Virtual via Webex)

                             

                            • Monday March 24, 2025: 10:00am – 1:00pm (In Person)

                                      Location: Whetten Graduate Center, Giolas Conference Room, 2nd floor

                             

                            • Wednesday April 9, 2025: 3:30pm – 6:30pm (Virtual via Webex)

                             

                            • Tuesday April 22, 2025: 10:00am – 1:00pm (In Person)

                                      Location: Whetten Graduate Center, 2nd floor, Room 211

                             

                            • Wednesday May 14, 2025: 10:00am – 1:00pm (Virtual via Webex)

                             

                             

                            To schedule an in-person or virtual appointment, please follow the link below:

                            https://nexus.uconn.edu/secure_per/schedule1.php?stser=4475

                             

                            RIC Education & Training Sessions

                            The RIC office also offers educational and training sessions for researchers, research teams, and classes on topics, such as informed consent, successful IRB submissions, post-approval research management, category of review, research subject to FDA regulations, and other human subjects research best practices.

                             

                            For questions about IRB office hours or educational sessions, please contact Joan Levine at joan.levine@uconn.edu.

                             

                             

                             

                             

                             

                             

                             

                             

                            Subaward Resources

                            Forms

                            Subrecipient Information and Compliance Form – To be provided along with subaward proposal documentation (scope of work, detailed budget and budget justification, additional documents required by proposal guidelines) when forwarded to Pre-Award Services (as part of an initial prime application/proposal) or in support of requests to sponsor for post-award addition of subaward/subcontract

                            Subrecipient Profile Questionnaire – Requested by SPS from subrecipients who are not members of the Federal Demonstration Partnership (FDP) to collect information used during required SPS risk assessment

                            External Investigator Financial Disclosure Form – Completion required by all responsible personnel from other institutions which do not have a compliant Financial Conflict of Interest policy.

                            Other Resources

                            Provides full instructions for initiating a subaward-related Purchase Requisition (for new subawards) or Purchase Order Action (for subaward amendments).

                            Provides a listing of subaward-related actions corresponding to common prime award activities.

                            New Researchers

                            Welcome to UConn!

                            We’re excited to have you join our research community. To ensure compliance with local, state, and federal regulations, all projects involving biological materials at UConn must be reviewed and approved by the Institutional Biosafety Committee (IBC) prior to the start of any research activities.

                             


                            Getting Started with HuskySMS

                            Before research can begin, Environmental Health and Safety (EHS) must add your lab to the HuskySMS database; uconn.scishield.com.  Once your lab’s dashboard is set up, Principal Investigators (PIs) and lab personnel can log in using your UConn NetID and password and will have access to the following:

                            Lab Dashboard

                            • General lab information
                            • Hazard listings
                            • Compliance summary

                            Training Module

                            • Assign applicable job activities to lab members under the “Members” tab
                            • Ensures required safety trainings are automatically prompted

                            Inspections Module

                            • Tracks lab safety and compliance inspections

                            Bio Module

                            • Used for IBC registration review and approval (see below for details)

                             


                            Complete the IBC Registration (Biological Summary)

                            All IBC registrations are submitted through the HuskySMS system; uconn.scishield.com. Log in using your UConn NetID and password.

                            Bio Profilefrom lab dashboard, click “Bio” tab

                            • Summary: Overview of lab projects and biological materials
                            • Registration Summary: Displays IBC submission status, review history, approval dates, and registration renewal deadlines

                            IBC Registrationdrop-down lab in left nav, click “Bio Summary” 

                            • Initial set up is done using the Biological Registration Wizard which guides you through completing the required forms.
                            • Upon logging into HuskySMS, prompts to complete the Biological Registration Wizard can be found at the top of your home page. These reminders will continue until submission.
                            • Complete one Project Form, which depending on the biological materials selected, may prompt additional surveys, tables, or forms (e.g., Pathogen Registration Form, Viral Vector Form).
                            • Amendments can be submitted by updating applicable sections of the approved bio-summary. Please be sure the registration status is NOT under “IBC Review”. Edits during this stage of review can delay approvals.
                            • Once complete, certify and submit for IBC review.

                            Tip: Only one Research Project Form should be completed per bio-summary. If you have multiple projects, list them in the “Description of Experimental and Procedural Details” section (e.g., Project 1: …, Project 2: …). This helps avoid duplicate submissions and streamlines the review process.

                            Resources

                            The IBC Guidance Document on the EHS website provides step-by-step instructions for completing your registration. Additional Quick Guides and Job Aids are also available on the EHS website.

                            Timeline

                            Determining when research can begin depends on the nature of the work being conducted. Once the IBC receives your biological summary, a determination will be made regarding when lab activities may commence.

                            See Level of Review Required below for additional details.

                             


                            Level of Review Required

                            UConn’s IBC review process includes two categories, based on the type of work proposed:

                            Full Committee Review
                            Required for projects involving:

                            • Covered experiments under the NIH Guidelines
                            • Risk Group 2 (RG2) pathogens
                            • Biological toxins

                            Administrative Review by the Biosafety Officer (BSO)
                            The IBC has delegated authority to the BSO for certain submissions, with notification to the full committee at the next scheduled meeting. These include:

                            • Projects classified as exempt under NIH Guidelines
                            • Work that does not involve recombinant or synthetic nucleic acid molecules

                             


                            Submission Deadlines

                            To be included for review during the next IBC meeting agenda, please submit your registration by the applicable submission deadline which can be found on the IBC Meeting Dates page.

                             


                            Questions?

                            If you have any questions about the HuskySMS Bio Module or the IBC registration process, feel free to contact us at ibc@uconn.edu.

                             


                             

                            Last Revised: March 12, 2026